In the study, published in Science Translational Medicine on Nov. 5, researchers identified proteins expressed on the surface ...

A recent study found that markers of platelet activity are increased in plasma of patients with pulmonary tuberculosis and these are then normalized with antimycobacterial treatment. The researchers ...

The MHRA has approved Siiltibcy, a new skin test that uses recombinant proteins to more accurately detect tuberculosis in ...

A new compound called CMX410 may change the fight against tuberculosis. It targets a weak point in the bacteria’s defenses, ...

A groundbreaking compound may finally give doctors the upper hand against drug-resistant tuberculosis, offering safer and ...

According to the Centers for Disease Control and Prevention, a tuberculosis infection-control program should consist of administrative controls, environmental controls and a respiratory-protection ...

Untreated tuberculosis may result in several long-term complications, such as permanent lung damage. It’s vital for the condition to be treated early to prevent the infection from traveling to other ...

Tuberculosis (TB) is the world’s deadliest infectious disease. In 2023, about 10.8 million people contracted TB, and 1.25 million people died from it, according to the World Health Organization.

Tuberculosis (TB) latency involves infection with the bacteria that also cause active TB. However, people with TB latency do not have symptoms. Treatment for TB latency can help reduce the risk of ...

Tuberculosis (TB) primarily affects the lungs. However, TB-causing bacteria can lead to pus collecting in the tissues. This is known as an abscess. Mycobacterium tuberculosis (M. tuberculosis) is the ...